We specialize in providing comprehensive solutions centered around bacteriophage technology. Our mission is to offer effective alternatives to traditional antibiotics, addressing some of the most pressing healthcare challenges of our time. Founded and led by Dr. Bálint Kintses, an expert in the field of antibiotic resistance and phage therapy, our company is dedicated to advancing innovative treatments that make a real difference in patient care. Dr. Kintses's recent research, published in Cell, demonstrates the potential of genomic surveillance to guide precision phage therapy in targeting resistant bacterial strains.